Article

Glaucoma 2005 convenes in San Francisco this September

The agenda is set for Glaucoma 2005 on Saturday, Sept. 17 at the Ritz-Carlton, San Francisco, with a program aimed at helping ophthalmologists master the tools and techniques of glaucoma diagnosis and therapy.

Major topics will include the benefits and limitations of new diagnostic technologies and how to integrate them into clinical practice, an evidence-based clinical approach to risk assessment in the ocular hypertensive and glaucoma patient, innovations in surgery for the patient with glaucoma, and challenging clinical cases.

Upon completion of this course, participants will have learned specific benefits and limitations of diagnostic technologies, practical approaches to risk assessment and management of the patient with suspected glaucoma, advances in surgical techniques, and practical approaches to challenging glaucoma cases. Participants will be able to incorporate their knowledge of these advances in glaucoma diagnosis and therapy into their clinical practices, thus providing the best possible care to their patients, either directly or through appropriate informed referrals.

The University of Medicine and Dentistry of New Jersey Center for Continuing and Outreach Education designates this educational activity for a maximum of 6 hours of category 1 credit toward the AMA Physician’s Recognition Award. The program is supported through an unrestricted educational grant from Pfizer Ophthalmics. To register or request more information, call 888/248-0036 or 218/723-9130 or visit http://otcme.com.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
© 2025 MJH Life Sciences

All rights reserved.